Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pygopus family PHD finger 1 (PYGO1) is a nuclear protein containing a plant homeodomain (PHD) zinc finger, acting as a transcription co-activator and chromatin modulator, and is a core component of the Wnt/β-catenin signaling complex[1][2][4][7]. It binds methylated histones and associates with transcriptional co-factors (such as BCL9/BCL9L), regulating gene expression during embryogenesis, development, and in cancer. PYGO1, along with its paralog PYGO2, plays a modulatory role in canonical Wnt signaling by linking nuclear β-catenin to chromatin regulation, affecting organ development (especially kidney and reproductive tissues) and certain malignancies[1][7]. No approved drugs are currently known to target PYGO1 directly, but its critical signaling role makes it a potential therapeutic target in Wnt-driven cancers and developmental disorders[7].
null (not specified for drugs, as none are reported directly targeting the protein; mechanisms would likely involve inhibition of Wnt/β-catenin pathway co-activation if discovered)[1][2][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pygopus family PHD finger 1 (PYGO1).